ARCELLX, INC. Share | Buy US Stock from India on Kuvera

Q: Can I buy ARCELLX, INC. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell ARCELLX, INC. stocks after a simple registration process. </div>

Q: How to buy ARCELLX, INC. shares in India?

<div> To buy ARCELLX, INC. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for ARCELLX, INC. and you are done!</div> </div>

Q: What is the share price of ARCELLX, INC.?

<div>The share price of ARCELLX, INC. is USD 78.16 as on 18 Dec.</div>

Q: What is the Market Capitalization of ARCELLX, INC.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of ARCELLX, INC. is USD 4.23B as on 18 Dec.</div>

Q: What is the PE ratio of ARCELLX, INC.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of ARCELLX, INC. is N/A as on 18 Dec. </div>

Q: Is ARCELLX, INC. a good stock to buy?

<div>Kuvera provides relevant fundamental details of ARCELLX, INC. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does ARCELLX, INC. operate?

<div> ARCELLX, INC. operates in Healthcare / Biotechnology

Healthcare Biotechnology

$78.16

-3.82

(7:41 pm IST)

Loading Chart

Previous close

$78.16

Open

$78.16

Today’s high

$83.35

Today’s low

$77.24

52W low

$47.88

52W high

$107.37

56.94%

EPS (TTM)

-0.71

Shares O/S

54.07M

Market cap

4.23B

Insights

ACLX has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.

ACLX is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.

In beta. Send feedback here.

Compare with other stock

About ARCELLX, INC.

Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM).

The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts). .

FAQs

Can I buy ARCELLX, INC. shares in India?

How to buy ARCELLX, INC. shares in India?

What is the share price of ARCELLX, INC.?

What is the Market Capitalization of ARCELLX, INC.?

What is the PE ratio of ARCELLX, INC.?

Is ARCELLX, INC. a good stock to buy?

In which sector / industry does ARCELLX, INC. operate?